• Info
  • Insider Ownership

Insider Trading & Ownership of Carmen Chang

Location
Menlo Park, CA
Summary
The estimated net worth of Carmen Chang is at least $377,973,192 dollars as of 06 Oct 2025. Carmen Chang is the 10%+ Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $146.15M. Carmen Chang is the 10%+ Owner of Savara Inc and owns shares of Savara Inc (SVRA) stock worth about $108.9M. Carmen Chang is the 10%+ Owner of Korro Bio, Inc. and owns shares of Korro Bio, Inc. (KRRO) stock worth about $61.08M. Carmen Chang is the 10%+ Owner of MBX Biosciences, Inc. and owns shares of MBX Biosciences, Inc. (MBX) stock worth about $38.64M. Carmen Chang is the Director of Coursera, Inc. and owns shares of Coursera, Inc. (COUR) stock worth about $20.07M. Carmen Chang is the 10%+ Owner of Trevi Therapeutics, Inc. and owns shares of Trevi Therapeutics, Inc. (TRVI) stock worth about $1.92M. Carmen Chang is the 10%+ Owner of Metacrine, Inc. and owns shares of Metacrine, Inc. stock worth about $1.2M. Carmen Chang is the 10%+ Owner of Mirum Pharmaceuticals, Inc. and owns shares of Mirum Pharmaceuticals, Inc. (MIRM) stock worth about $3.8K.
Signature
/s/ Zachary Bambach, attorney-in-fact
All Insider Reports
All Insider Reports

Notify me when Carmen Chang files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Carmen Chang

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
GLUE Monte Rosa Therapeutics, Inc. 10%+ Owner $146,153,662 28 Jun 2021
SVRA Savara Inc 10%+ Owner $108,897,125 17 Jul 2023
KRRO Korro Bio, Inc. 10%+ Owner $61,084,408 22 Apr 2024
MBX MBX Biosciences, Inc. 10%+ Owner $38,638,855 16 Sep 2024
COUR Coursera, Inc. Director $20,073,751 21 May 2025
TRVI Trevi Therapeutics, Inc. 10%+ Owner $1,916,875 11 Apr 2022
MTCR Metacrine, Inc. 10%+ Owner $1,204,731 10 Dec 2021
MIRM Mirum Pharmaceuticals, Inc. 10%+ Owner $3,785 13 Jun 2023
NEUE NeueHealth, Inc. Director, 10%+ Owner $0 -$26,426 -100% 02 Oct 2025
AKUS Akouos, Inc. 10%+ Owner 30 Nov 2022
GNCA GENOCEA BIOSCIENCES, INC. 10%+ Owner 24 May 2022

Insider Transactions Reported by Carmen Chang:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.